567 Efficacy of checkpoint inhibitor immunotherapy drug pembrolizumab (KEYTRUDA) for treatment of advanced cervical cancer

F Ahmed; Z Shah; I Khan; A Bhatnagar; R Garimella; S Mishra; S Gudapati; SH Bobba; S Zaidi; K Andrews; U Salman; Z Yukselen; P Guntipalli; R Zarrar; G Enebong Nya; S Ahmad

doi:10.1136/ijgc-2021-ESGO.43

Article info

Cervical cancer

567 Efficacy of checkpoint inhibitor immunotherapy drug pembrolizumab (KEYTRUDA) for treatment of advanced cervical cancer

Free

Authors

F Ahmed Larkin Community Hospital, Division of Clinical and Translational Research, South Miami, USA PubMed articles Google scholar articles
Z Shah Weiss Memorial Hospital, Department of Internal Medicine, Chicago, USA PubMed articles Google scholar articles
I Khan Larkin Community Hospital, Division of Clinical and Translational Research, South Miami, USA PubMed articles Google scholar articles
A Bhatnagar Larkin Community Hospital, Division of Clinical and Translational Research, South Miami, USA PubMed articles Google scholar articles
R Garimella Larkin Community Hospital, Division of Clinical and Translational Research, South Miami, USA PubMed articles Google scholar articles
S Mishra Larkin Community Hospital, Division of Clinical and Translational Research, South Miami, USA PubMed articles Google scholar articles
S Gudapati Washington University of Health and Science, College of Medicine, San Pedro, Belize PubMed articles Google scholar articles
SH Bobba Washington University of Health and Science, College of Medicine, San Pedro, Belize PubMed articles Google scholar articles
S Zaidi Lahore Medical and Dental College, College of Medicine, Lahore, Pakistan PubMed articles Google scholar articles
K Andrews Prince Mohammad Bin Fahad University, Department of CORE, Al Khobar, Saudi Arabia PubMed articles Google scholar articles
U Salman Bakhtawar Amin Medical and Dental College, College of Medicine, Multan, Pakistan PubMed articles Google scholar articles
Z Yukselen Larkin Community Hospital, Division of Clinical and Translational Research, South Miami, USA PubMed articles Google scholar articles
P Guntipalli Larkin Community Hospital, Division of Clinical and Translational Research, South Miami, USA PubMed articles Google scholar articles
R Zarrar Mayo Clinic, Department of Oncology, Rochester, USA PubMed articles Google scholar articles
G Enebong Nya John Hopkins Hospital, Department of Gynecologic Oncology, Baltimore, USA PubMed articles Google scholar articles
S Ahmad Advent Health Cancer Institute, Division of Gynecologic Oncology, Orlando, USA PubMed articles Google scholar articles

Citation

Ahmed F, Shah Z, Khan I, et al

567 Efficacy of checkpoint inhibitor immunotherapy drug pembrolizumab (KEYTRUDA) for treatment of advanced cervical cancer

International Journal of Gynecologic Cancer 2021;31:A32.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password